Compound ID | 2920
Class: Beta-lactam
| Agent Type: | Semisynthetic; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-negative |
| Mechanism of action: | Cell wall synthesis inhibitor |
| Target Pathogen: | Active against Escherichia coli, Acinetobacter baumannii, Klebsiella pneumoniae, and Pseudomonas aeruginosa |
| Description: | Semisynthetic compound; catechol-conjugated beta-lactam; shows stronger iron-chelating capacity than cefiderocol; in vivo efficacy is comparable to cefiderocol in Acinetobacter baumannii infection in mice |
| Year first mentioned: | 2024 |
| Development status: | Experimental |
| External links: | |
| Citation: | https://pubs.acs.org/doi/10.1021/acs.jmedchem.4c00265 |